DK2686005T3 - Topikale sammensætninger omfattende diaminooxidase til behandlingen eller forebyggelsen af sygdomme associeret med høje histaminniveauer, som involverer en stigning i smerte - Google Patents

Topikale sammensætninger omfattende diaminooxidase til behandlingen eller forebyggelsen af sygdomme associeret med høje histaminniveauer, som involverer en stigning i smerte Download PDF

Info

Publication number
DK2686005T3
DK2686005T3 DK12711461.9T DK12711461T DK2686005T3 DK 2686005 T3 DK2686005 T3 DK 2686005T3 DK 12711461 T DK12711461 T DK 12711461T DK 2686005 T3 DK2686005 T3 DK 2686005T3
Authority
DK
Denmark
Prior art keywords
composition
dao
use according
weight
pain
Prior art date
Application number
DK12711461.9T
Other languages
English (en)
Inventor
Riu Carlos Duelo
Riu Juan José Duelo
Original Assignee
Dr Healthcare Espana S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Healthcare Espana S L filed Critical Dr Healthcare Espana S L
Application granted granted Critical
Publication of DK2686005T3 publication Critical patent/DK2686005T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1213—Oxidation or reduction enzymes, e.g. peroxidase, catalase, dehydrogenase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03006—Amine oxidase (copper-containing)(1.4.3.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03022—Diamine oxidase (1.4.3.22)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C2210/00—Physical treatment of dairy products
    • A23C2210/40—Microencapsulation; Encapsulation of particles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)

Claims (9)

1. Farmaceutisk, kosmetisk eller dermokosmetisk sammensætning omfattende diaminooxidase (DAO), til anvendelse i forebyggelsen eller behandlingen af sygdomme eller patologiske lidelser valgt fra gruppen udgjort af fibromyalgi, spondylitis og muskelkontrakturer, kendetegnet ved, at påføringen af nævnte sammensætning ertopikal.
2. Sammensætning til anvendelse ifølge krav 1, kendetegnet ved, at nævnte sammensætning er en creme, et serum, en gel, en hydrogel, en olie, et bioadhæsivt plaster eller en spray.
3. Sammensætning til anvendelse ifølge et hvilket som helst af kravene 1 eller 2, kendetegnet ved, at DAO er i formen af et pulver, et lyofiliseret pulver, eller indkapslet i en nanopartikel, mikropartikel eller liposom.
4. Sammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 3, kendetegnet ved, at DAO er af bioteknologisk oprindelse, eller af plante- eller dyreudvinding.
5. Sammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 4, kendetegnet ved, at DAO fortrinsvis er af plante- eller dyreudvinding.
6. Sammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 5, kendetegnet ved, at koncentrationen af DAO i nævnte topikale sammensætninger er i området mellem 0,005 og 20 vægtprocent.
7. Sammensætning til anvendelse ifølge krav 6, kendetegnet ved, at koncentrationen af DAO i nævnte topikale sammensætninger fortrinsvis er i området mellem 0,5 og 5 vægtprocent.
8. Sammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 7, kendetegnet ved, at nævnte sammensætning i formen af et plaster er et fleksibelt bioadhæsivt plaster, der omfatter: a) en terapeutisk effektiv mængde af DAO i pulverform, b) et farmaceutisk acceptabelt solvent i en mængde i området mellem cirka 5 og cirka 70 vægtprocent i forhold til den totale vægt af sammensætningen, hvor solventet inkluderer cirka mellem 5 og 50 vægtprocent af et blødgøringsmiddel, og c) en farmaceutisk acceptabelt bioadhæsiv bærer i en koncentration i området mellem cirka 20 og 50 vægtprocent i forhold til vægten af den komplette sammensætning, hvor sammensætningen er i alt væsentligt vandfri, i alt væsentligt uopløselig i vand og bioadhæsiv.
9. Sammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 8, kendetegnet ved, at nævnte sammensætning i formen af en creme, et serum, en gel, en hydrogel eller en olie er påført til en medicinsk indretning, hvorfra det frigives på en kontrolleret måde til området påvirket af smerte.
DK12711461.9T 2011-03-18 2012-03-15 Topikale sammensætninger omfattende diaminooxidase til behandlingen eller forebyggelsen af sygdomme associeret med høje histaminniveauer, som involverer en stigning i smerte DK2686005T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201130381A ES2387973B1 (es) 2011-03-18 2011-03-18 Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor.
PCT/IB2012/051252 WO2012127381A1 (en) 2011-03-18 2012-03-15 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain

Publications (1)

Publication Number Publication Date
DK2686005T3 true DK2686005T3 (da) 2018-10-08

Family

ID=46846158

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12711461.9T DK2686005T3 (da) 2011-03-18 2012-03-15 Topikale sammensætninger omfattende diaminooxidase til behandlingen eller forebyggelsen af sygdomme associeret med høje histaminniveauer, som involverer en stigning i smerte

Country Status (13)

Country Link
US (1) US20140004180A1 (da)
EP (1) EP2686005B1 (da)
CN (1) CN103476422A (da)
BR (1) BR112013023703A2 (da)
CO (1) CO6801743A2 (da)
DK (1) DK2686005T3 (da)
ES (2) ES2387973B1 (da)
HU (1) HUE040124T2 (da)
MX (1) MX358072B (da)
PL (1) PL2686005T3 (da)
PT (1) PT2686005T (da)
RU (1) RU2616248C2 (da)
WO (1) WO2012127381A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12201676B2 (en) 2011-03-18 2025-01-21 Dr Healthcare España, S.L. Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1313318A (en) * 1969-10-07 1973-04-11 Urbin M C Pharmaceutical preparation for the treatment of hemorrhoids
FR2101095A1 (en) * 1970-08-20 1972-03-31 Merieux Inst Diamine oxidase from human placenta - for treatment of hyperhistamina
FR2215944A1 (en) * 1973-02-01 1974-08-30 Bellon Labor Sa Roger Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies
GB8319540D0 (en) 1983-07-20 1983-08-24 Bovril Ltd Amine removal
US4725540A (en) 1984-07-09 1988-02-16 Emil Underberg Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material
US4851243A (en) 1987-10-08 1989-07-25 Borden, Inc. Calcium fortified aseptically packaged milk
JPH06502310A (ja) 1990-10-31 1994-03-17 ザ、プロクター、エンド、ギャンブル、カンパニー カルシウム強化ソース
MX9707584A (es) 1995-04-07 1998-02-28 Abbott Lab Complementos de calcio y bebidas que contienen calcio y que comprenden vitamina d.
US5855936A (en) 1997-03-21 1999-01-05 Nestec S.A. Food fortification
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
IT1317067B1 (it) * 2000-11-29 2003-05-26 Univ Roma Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
AT502098B8 (de) * 2004-07-07 2007-06-15 Albert Dr Missbichler Diaminooxidase-hältige zusammensetzung
AT502850B1 (de) * 2005-11-18 2007-08-15 Albert Dr Missbichler Verfahren zur bestimmung der aktivität von diaminooxidase
US20110236491A1 (en) * 2010-03-25 2011-09-29 Jeannette Chantalat Topical anti-inflammatory composition

Also Published As

Publication number Publication date
PT2686005T (pt) 2018-10-26
RU2616248C2 (ru) 2017-04-13
CO6801743A2 (es) 2013-11-29
MX2013010689A (es) 2013-10-03
BR112013023703A2 (pt) 2016-12-13
WO2012127381A1 (en) 2012-09-27
ES2387973A1 (es) 2012-10-04
CN103476422A (zh) 2013-12-25
ES2387973B1 (es) 2013-10-01
MX358072B (es) 2018-08-03
RU2013144969A (ru) 2015-04-27
HUE040124T2 (hu) 2019-02-28
US20140004180A1 (en) 2014-01-02
PL2686005T3 (pl) 2018-12-31
EP2686005A1 (en) 2014-01-22
ES2688343T3 (es) 2018-11-02
EP2686005B1 (en) 2018-06-27

Similar Documents

Publication Publication Date Title
JP2002538802A (ja) ポリフェノールに富むブドウ抽出物に基いた、フードコンプリメントおよび美容処置のための方法
US12516300B2 (en) Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
DK2686005T3 (da) Topikale sammensætninger omfattende diaminooxidase til behandlingen eller forebyggelsen af sygdomme associeret med høje histaminniveauer, som involverer en stigning i smerte
JP2007501846A5 (da)
KR20140139949A (ko) 난각막 성분을 포함한 시르투인 유전자 활성화제 및 그것을 이용한 조성물
CA2676795A1 (en) Skin-beautifying agent
WO2021113411A1 (en) Transdermal penetrant formulations for vitamins, minerals and supplements
JP5646477B2 (ja) キトサンおよびジカルボン酸を含む、酒さ疾患を治療するための組成物
WO2007142130A1 (ja) マイタケ抽出物及びこれを含む皮脂産生を促進するための組成物
EP2686004B1 (en) Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
WO2004028531A1 (ja) 褥瘡の予防剤または治療剤
EP3744323A1 (en) Composition for preventing or improving nociceptive pain
JP3404235B2 (ja) 抗肥満剤
EP2692332B1 (en) Composition for the treatment of callus, corns and psoriasis
HK1192478A (en) Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
WO2006090940A1 (en) Composγπon for prevention and treatment of stretch mark comprising citric acid, zinc and arginine
JP7781615B2 (ja) Ａｂｃａ１２産生促進用組成物
El-Seddawy et al. Dexpanthenol: New Insights on Wound Healing, a Review
JP2017088558A (ja) セラミド合成促進剤
CN106265112B (zh) 促进伤口愈合的药物或化妆用组合物
WO2014143629A1 (en) Bimatoprost for enhancement of leptin production
JP2005325034A (ja) 一重項酸素消去剤
JP2023144448A (ja) 抗アレルギー剤
TW202009005A (zh) 具抗氧化活性之組合物
CN112804985A (zh) 可的松还原酶阻碍用组合物